Diabetes Care 28 , 10921100 (2005)
Similar content being viewed by others Background Type 2 diabetes (T2D) shares several cardiometabolic and prognostic factors that are highly correlated with the development of non-alcoholic fatty liver disease (NAFLD) [1, 2]
Small adjustments can make the difference between short-term success and long-term sustainability
However, their effectiveness and risks have not yet been systematically evaluated in a comprehensive set of possible health outcomes
Key markers include comprehensive metabolic panel (to monitor kidney function and electrolytes), lipid panel, hemoglobin A1c (for diabetic patients), liver function tests, and thyroid function
Thats the mechanism that helps people treat obesity and manage weight